Vimarsana
Biggest News Aggregation in the World

Daniel Tenen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Tenen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Tenen Today - Breaking & Trending Today

2023 HBS New Venture Competition: Bringing Out the Best in HBS Students and Alumni, with Ideas and Ventures to Change the World - Vimarsana News

2023 HBS New Venture Competition: Bringing Out the Best in HBS Students and Alumni, with Ideas and Ventures to Change the World

/PRNewswire/ -- Harvard Business School's (HBS) Klarman Hall was packed to capacity yesterday evening, with spectators there to support the 12 student finalist...

Cancer Genes Activated by Common Drugs for Medicament Lobbies Early Diagnosis, Treatment - Vimarsana News

Cancer Genes Activated by Common Drugs for Medicament Lobbies Early Diagnosis, Treatment

A team of doctors has discovered that common drugs for treating MDS can turn on cancer genes, which can be used for early diagnosis and treatment.

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene - Vimarsana News

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingly in other diseases, but their mechanism of action remains unclear.

Drugs used to treat blood cancer could activate "sleeping" cancer-causing gene – India Education | Latest Education News | Global Educational News - Vimarsana News

Drugs used to treat blood cancer could activate "sleeping" cancer-causing gene – India Education | Latest Education News | Global Educational News

Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasing

NUS researchers identify novel pathways responsible for liver cancer - Vimarsana News

NUS researchers identify novel pathways responsible for liver cancer

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year. HCC occurs most often in peopl